The effect of intravenously administered papaverine hydrochloride on the regional cerebral blood flow (rCBF) was determined in the contralateral hemispheres of 6 patients with acute unilateral cerebral infarction. In all 6 patients, the resting state rCBF was reduced in the noninfarcted hemisphere. Papaverine increased the hemispheric mean rCBF in only 1 patient, whereas abnormal responses were observed in 5 subjects. Mean hemispheric flow values decreased paradoxically in 2 patients and remained unchanged in 3. Individual rCBF values increased in the entire contralateral hemisphere in 1 patient. Widespread paradoxical rCBF decreases were observed in another subject. Mixed regional responses to papaverine, showing decreases, no change and increases in rCBF values occurred in the opposite hemispheres of 4 patients. These findings provide additional evidence that the chem-ical control of rCBF may be impaired in the contralateral ‘unaffected’ hemisphere soon after the onset of acute cerebral infarction.

Keywords:
Regional cerebral blood flow, Cerebral infarction, Noninfarcted, contralateral hemisphere, Papaverine HC1
This content is only available via PDF.
© 1979 S. Karger AG, Basel
1979
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.